Axonal transport and amyotrophic lateral sclerosis

2021 ◽  
pp. 309-321
Author(s):  
Andy Grierson ◽  
Chris Miller
Nature ◽  
1995 ◽  
Vol 375 (6526) ◽  
pp. 61-64 ◽  
Author(s):  
Jean-François Collard ◽  
Francine Côté ◽  
Jean-Pierre Julien

2007 ◽  
Vol 16 (22) ◽  
pp. 2720-2728 ◽  
Author(s):  
Kurt J. De Vos ◽  
Anna L. Chapman ◽  
Maria E. Tennant ◽  
Catherine Manser ◽  
Elizabeth L. Tudor ◽  
...  

1997 ◽  
Vol 139 (5) ◽  
pp. 1307-1315 ◽  
Author(s):  
Bin Zhang ◽  
Pang-hsien Tu ◽  
Farhad Abtahian ◽  
John Q. Trojanowski ◽  
Virginia M.-Y. Lee

Mice engineered to express a transgene encoding a human Cu/Zn superoxide dismutase (SOD1) with a Gly93 → Ala (G93A) mutation found in patients who succumb to familial amyotrophic lateral sclerosis (FALS) develop a rapidly progressive and fatal motor neuron disease (MND) similar to amyotrophic lateral sclerosis (ALS). Hallmark ALS lesions such as fragmentation of the Golgi apparatus and neurofilament (NF)-rich inclusions in surviving spinal cord motor neurons as well as the selective degeneration of this population of neurons were also observed in these animals. Since the mechanism whereby mutations in SOD1 lead to MND remains enigmatic, we asked whether NF inclusions in motor neurons compromise axonal transport during the onset and progression of MND in a line of mice that contained ∼30% fewer copies of the transgene than the original G93A (Gurney et al., 1994). The onset of MND was delayed in these mice compared to the original G93A mice, but they developed the same neuropathologic abnormalities seen in the original G93A mice, albeit at a later time point with fewer vacuoles and more NF inclusions. Quantitative Western blot analyses showed a progressive decrease in the level of NF proteins in the L5 ventral roots of G93A mice and a concomitant reduction in axon caliber with the onset of motor weakness. By ∼200 d, both fast and slow axonal transports were impaired in the ventral roots of these mice coincidental with the appearance of NF inclusions and vacuoles in the axons and perikarya of vulnerable motor neurons. This is the first demonstration of impaired axonal transport in a mouse model of ALS, and we infer that similar impairments occur in authentic ALS. Based on the temporal correlation of these impairments with the onset of motor weakness and the appearance of NF inclusions and vacuoles in vulnerable motor neurons, the latter lesions may be the proximal cause of motor neuron dysfunction and degeneration in the G93A mice and in FALS patients with SOD1 mutations.


2012 ◽  
Vol 21 (9) ◽  
pp. 1979-1988 ◽  
Author(s):  
G. M. Morotz ◽  
K. J. De Vos ◽  
A. Vagnoni ◽  
S. Ackerley ◽  
C. E. Shaw ◽  
...  

2017 ◽  
Vol 26 (23) ◽  
pp. 4668-4679 ◽  
Author(s):  
Annekathrin Moller ◽  
Claudia S Bauer ◽  
Rebecca N Cohen ◽  
Christopher P Webster ◽  
Kurt J De Vos

2012 ◽  
Vol 109 (11) ◽  
pp. 4296-4301 ◽  
Author(s):  
P. Marinkovic ◽  
M. S. Reuter ◽  
M. S. Brill ◽  
L. Godinho ◽  
M. Kerschensteiner ◽  
...  

2021 ◽  
Author(s):  
Andrew P. Tosolini ◽  
James N. Sleigh ◽  
Sunaina Surana ◽  
Elena R. Rhymes ◽  
Stephen D. Cahalan ◽  
...  

AbstractAxonal transport ensures long-range delivery of essential cargoes between proximal and distal compartments of neurons, and is needed for neuronal development, function, and survival. Deficits in axonal transport have been detected at pre-symptomatic stages in mouse models of amyotrophic lateral sclerosis (ALS), suggesting that impairments are fundamental for disease pathogenesis. However, the precise mechanisms responsible for the transport deficits and whether they preferentially affect α-motor neuron (MN) subtypes remain unresolved. Here, we report that stimulation of wild-type neurons with brain-derived neurotrophic factor (BDNF) enhances trafficking of signalling endosomes specifically in fast MNs (FMNs). In early symptomatic SOD1G93A mice, FMNs display selective impairment of axonal transport and develop an insensitivity to BDNF stimulation, with pathology upregulating classical non-pro-survival receptors in muscles and sciatic nerves. Altogether, these data indicate that cell- and non-cell autonomous BDNF signalling is impaired in vulnerable SOD1G93A MNs, thus identifying a new key deficit in ALS amenable for future therapeutic interventions.


Sign in / Sign up

Export Citation Format

Share Document